Dassault Systemes' 3DEXPERIENCE platform anchors mission-critical CAD/PLM workflows across aerospace, automotive, life sciences, and industrial markets. Medidata clinical trials platform delivers consistent double-digit SaaS growth. Life Sciences and Mainstream Innovation (SOLIDWORKS) provide growth alongside the slower Industrial Innovation segment. Generative AI integration (3DEXPERIENCE Cloud Copilot) is in early innings. Family-controlled with disciplined capital allocation but premium valuation requires execution.
Thesis reviewed May 29, 2026
Dassault Systemes SE is headquartered in France, which is currently showing moderate signals.
π«π·France48NEUTRALView France risk detail βπ»Technology45WATCH| Ticker | Company | Score | Gap | Signal Ξ | Action |
|---|---|---|---|---|---|
| NTES | NetEase Inc | 46 | +10% | β8% | EARLY |
| BABA | Alibaba Group Holding Ltd | 46 | +17% | β8% | EARLY |
| SAP | SAP SE | 46 | +8% | β8% | EARLY |
| PSO | Pearson PLC | 46 | +10% | β8% | NEUTRAL |
| ACN | Accenture plc | 46 | +7% | β8% | NEUTRAL |
| TCS | Tata Consultancy Services Ltd | 46 | +11% | β8% | EARLY |
| WIT | Wipro Ltd | 46 | +6% | β8% | NEUTRAL |
Investors who hold DASTY may also have indirect exposure through these country funds.
Dassault Medidata wins major top-20 pharma clinical platform contract
3DEXPERIENCE Copilot AI integration enters general availability
Estimates Β· Yahoo Finance Β· Not audited figures
| Politician | Party | Type | Amount | Trade Date | Return |
|---|---|---|---|---|---|
| Josh GottheimerNJ | D | Sell | $1kβ$15k | Jun 18, 24 | -38.5% |